FDA APPROVES TEZSPIRE™ (TEZEPELUMAB-EKKO) IN THE U.S. FOR SEVERE ASTHMA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. CIEN
9. GWRE
10. CPB

Go back to FDA APPROVES TEZSPIRE™ (TEZEPELUMAB-EKKO) IN THE U.S. FOR SEVERE ASTHMA
Amgen Inc (NASDAQ: AMGN) Delayed: 437.79 -6.33 (1.43%)
Previous Close $444.12    52 Week High $176.85 
Open $437.03    52 Week Low $133.64 
Day High $441.85    P/E 65.93 
Day Low $435.00    EPS $6.64 
Volume 447,054